Table 2: Antimetastatic and antiproliferative action by turmeric, its mechanisms of action, and their respective references.
Mechanisms of action |
Affection |
References |
Inhibition Notch-1 transcription fator |
Osteosarcoma cell lines |
LI, et al. [17] |
Wnt pathway inhibition |
Prostate cancer |
LU, et al. [18] |
Reduction in the expression of cyclin D1 (protein involved with G1-S cell cycle) |
Gastric cancer |
CAI, et al. [19] |
Inactivation of cyclin-dependent kinases (CDK), and increased mRNA of inhibitory genes p21 and p27 |
Pulmonary carcinoma (NCI-H460) |
SAHA, et al. [20] |
Inhibition of the cell cycle in phase G2/M |
Colon cancer (Rko and HCT116) |
MUDDULURU, et al. [21] |
Inhibition of the production of three proteins (Tcf-4, CBP and P300), related to Wnt transcription |
Prostate cancer (22rv1) |
TEITEN, et al. [22] |
Reduced expression of MMP-9 |
Breast cancer (metastasis) |
KIM, et al. [23] |
decrease in apoptotic sunburn cells, and decrease expression of proliferation nuclear antigen (PCNA) |
Skin cancer induced by ultraviolet radiation |
TSAI, et al. [24] |
inhibition of Notch-1 transcription factor (associated with increased proliferation and tumor invasion) |
Three osteosarcoma cell lines |
LI, et al. [25] |
Antiproliferative effects in SPC-A1 (in vitro and in vivo test) |
Human lung adenocarcinoma |
WANG, et al. [26] |
Decrease adhesion, migration, and proliferation (in vitro and in vivo test) |
Oral squamous cell carcinoma (OSCC), fibroblast cell lines and xenograft model of OSCC |
CAMPOS, et al. [27] |